Back

Catheter ablation of atrial fibrillation shows pulmonary vein dependent effect on the signal-averaged P-wave morphology

7 April 2024 (08:30 - 15:00)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation: clinical 2 Diagnostic Methods EHRA Premium Access EHRA 2024 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Mr Noah Fantazi

Evangelical Hospital, Bergisch Gladbach (Germany)

5 More presentations in this session

Presentation thumbnail
The circadian pattern of atrial fibrillation onset
Doctor M. Van den Broek (Eindhoven, NL)
Abstract Slides Video
Presentation thumbnail
Non-invasive mapping of atrial slow-conduction areas and validation by endocardial isochronal mapping to predict atrial fibrillation recurrence after ablation
Doctor T. Althoff (Berlin, DE)
Abstract Slides Video
Presentation thumbnail
Validation of CT in comparison to TEE in routine workflow for detection of LAA thrombus in patients under oral anticoagulation presenting for left atrial ablation
Miss H. Stolterfoht (Jena, DE)
Abstract Slides Video
Presentation thumbnail
Impact of iNAV and dNAV 3D LGE-CMR on the assessment of atrial fibrosis in atrial fibrillation patients
Mr L. Hopman (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
Standardized regionalization of the atria for 3D cardiac imaging, electroanatomical mapping and computational modeling. A multidisciplinary consensus of the PersonalizeAF consortium
Doctor T. Althoff (Berlin, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation: clinical 2
Video

The Event

Event poster

EHRA 2024

7 April - 9 April 2024
You may be interested in
thumbnail
Congress Presentation
Interactive discussion and Q&A
thumbnail
Congress Session
EHRA Myths - Device-detected atrial fibrillation
thumbnail
Congress Presentation
Device-detected or clinically diagnosed atrial fibrillation: the same decision for oral anticoagulation therapy - discussion

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources